Cubist Systematic Strategies LLC increased its stake in National Health Investors, Inc. (NYSE:NHI - Free Report) by 130.5% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 30,236 shares of the real estate investment trust's stock after acquiring an additional 17,118 shares during the period. Cubist Systematic Strategies LLC owned approximately 0.06% of National Health Investors worth $2,233,000 at the end of the most recent reporting period.
A number of other large investors have also recently added to or reduced their stakes in the business. Millennium Management LLC increased its stake in National Health Investors by 1,967.0% in the fourth quarter. Millennium Management LLC now owns 488,353 shares of the real estate investment trust's stock valued at $33,843,000 after acquiring an additional 464,727 shares during the period. Land & Buildings Investment Management LLC raised its holdings in shares of National Health Investors by 109.4% in the 4th quarter. Land & Buildings Investment Management LLC now owns 467,056 shares of the real estate investment trust's stock valued at $32,367,000 after purchasing an additional 243,999 shares during the period. MetLife Investment Management LLC grew its stake in National Health Investors by 706.6% in the 1st quarter. MetLife Investment Management LLC now owns 213,730 shares of the real estate investment trust's stock valued at $15,786,000 after buying an additional 187,233 shares during the last quarter. Bowen Hanes & Co. Inc. bought a new position in shares of National Health Investors during the first quarter worth approximately $10,340,000. Finally, Nuveen LLC acquired a new stake in National Health Investors in the first quarter valued at approximately $10,126,000. 62.51% of the stock is currently owned by institutional investors.
Analyst Upgrades and Downgrades
A number of brokerages recently weighed in on NHI. Truist Financial lifted their target price on shares of National Health Investors from $77.00 to $81.00 and gave the stock a "buy" rating in a research note on Friday, August 15th. KeyCorp raised shares of National Health Investors from a "sector weight" rating to an "overweight" rating and set a $80.00 price target for the company in a research note on Thursday, July 10th. Wells Fargo & Company lifted their price target on shares of National Health Investors from $76.00 to $80.00 and gave the company an "equal weight" rating in a research note on Wednesday, August 27th. Finally, Wedbush raised shares of National Health Investors to a "strong-buy" rating in a research note on Wednesday, July 2nd. One investment analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and one has issued a Hold rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of "Buy" and an average price target of $84.20.
Get Our Latest Research Report on National Health Investors
National Health Investors Stock Up 0.7%
National Health Investors stock traded up $0.54 during midday trading on Thursday, hitting $78.59. 71,406 shares of the stock were exchanged, compared to its average volume of 242,416. National Health Investors, Inc. has a 52-week low of $65.13 and a 52-week high of $86.13. The stock has a market capitalization of $3.73 billion, a price-to-earnings ratio of 25.07, a price-to-earnings-growth ratio of 3.37 and a beta of 0.76. The business's 50-day moving average price is $73.84 and its 200-day moving average price is $73.39. The company has a quick ratio of 10.91, a current ratio of 10.91 and a debt-to-equity ratio of 0.75.
National Health Investors (NYSE:NHI - Get Free Report) last announced its quarterly earnings results on Wednesday, August 6th. The real estate investment trust reported $1.22 EPS for the quarter, beating analysts' consensus estimates of $1.16 by $0.06. The company had revenue of $70.27 million for the quarter, compared to analysts' expectations of $86.46 million. National Health Investors had a net margin of 40.97% and a return on equity of 10.32%. National Health Investors's revenue was up 6.7% compared to the same quarter last year. During the same period in the prior year, the company posted $1.18 EPS. On average, research analysts expect that National Health Investors, Inc. will post 4.41 EPS for the current fiscal year.
National Health Investors Increases Dividend
The business also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Tuesday, September 30th will be issued a $0.92 dividend. This represents a $3.68 dividend on an annualized basis and a dividend yield of 4.7%. The ex-dividend date of this dividend is Tuesday, September 30th. This is a positive change from National Health Investors's previous quarterly dividend of $0.90. National Health Investors's payout ratio is currently 115.02%.
About National Health Investors
(
Free Report)
Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.
Featured Articles

Before you consider National Health Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National Health Investors wasn't on the list.
While National Health Investors currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.